LL-37

What is it?

LL-37 is an antimicrobial and immune-modulating peptide naturally produced by the body. It plays a major role in immune defense, infection control, wound healing, and inflammation regulation.

Key Benefits

• Supports immune function and infection defense

• Provides antimicrobial activity against bacteria, viruses, and fungi

• Promotes wound healing and tissue repair

• Helps regulate inflammation and immune balance

• Supports recovery through angiogenesis and tissue regeneration

Possible Side Effects

Usually mild:

• Injection site irritation

• Fatigue

• Headache

• Nausea

• Flu-like symptoms

Less common:

• Autoimmune flare-ups

• Increased inflammation

• Excessive angiogenesis

• Skin irritation with topical use

Use With Caution

Use under medical supervision if you have:

• Inflammatory bowel disease

• Severe asthma

• Chronic inflammatory conditions

Contraindications

Do not use if:

• Pregnant or breastfeeding

• Active cancer

• Lupus

• Multiple sclerosis

• Rheumatoid arthritis

• Psoriasis

• History of organ transplant

LL-37 Dosing Protocol (5mg)

Reconstitution

Mix:

• 5mg vial + 2.5mL (250 units) BAC water

General Guidelines

• Subcutaneous injection

• Cycle length: 8 to 12 weeks

• Washout: 4 to 8 weeks

• May be taken any time of day

• Food not required

Frequency

• Weeks 1 to 4: 7 days weekly

• Weeks 5 to 12: 5 days weekly

Standard Protocol

Week 1

• 3 units (50mcg), once daily

Week 2

• 5 units (100mcg), once daily

Week 3

• 8 units (150mcg), once daily

Week 4

• 10 units (200mcg), once daily

Week 5

• 13 units (300mcg), once daily

Week 6

• 15 units (350mcg), once daily

Week 7

• 18 units (400mcg), once daily

Weeks 8 to 12

• 20 units (450mcg), once daily